Eur Rev Med Pharmacol Sci 2022; 26 (5): 1579-1585
DOI: 10.26355/eurrev_202203_28224

Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia

A. Yazici, M. Buyuktiryaki, G.K. Simsek, H.G. Kanmaz Kutman, F.E. Canpolat

Ankara City Hospital, Division of Neonatology, Ankara, Turkey. aybukeyzc07@gmail.com


OBJECTIVE: Bronchopulmonary dysplasia (BPD) is a common and serious complication in preterm infants with very low birth weight and is known to lead to poor neurodevelopmental outcomes. This study aimed to identify factors associated with neurodevelopmental impairment (NDI) in patients with moderate to severe BPD.

SUBJECTS AND METHODS: A total of 83 preterm infants born between 24- and 29-weeks’ gestation who were admitted to the neonatal intensive care unit and developed moderate/severe BPD between 2013 and 2017 were retrospectively evaluated. Developmental assessment was performed at 18 to 24 months of corrected age using the Bayley Scales of Infant Development II (BSID-II). Patients with NDI (n=41) and without NDI (n=42) were compared.

RESULTS: BSID-II Mental Development Index and Psychomotor Development Index scores were 87±11 and 83±8 in the non-NDI group and 57±12 and 52±8 in the NDI group, respectively (p<0.001). The NDI group had significantly lower birth weight (847±174 vs. 1012±192 g) and gestational age (26.1±1.3 and 27.6±1.6 weeks) compared to the non-NDI group (p<0.001). Intraventricular hemorrhage, periventricular leukomalacia, retinopathy of prematurity, exposure to steroids, duration of respiratory support, and length of hospital stay were significantly higher in the NDI group (p<0.001).

CONCLUSIONS: Many of the conditions in this study were found to be associated with poor neurodevelopmental outcomes in patients with BPD, such as prolonged respiratory support, prolonged hospitalization, intraventricular hemorrhage, retinopathy, and steroid therapy, can be avoided or prevented with strict protocols and prevention strategies. Appropriate management of comorbid risk factors may help prevent poor neurodevelopmental outcomes.

Free PDF Download

To cite this article

A. Yazici, M. Buyuktiryaki, G.K. Simsek, H.G. Kanmaz Kutman, F.E. Canpolat
Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 5
Pages: 1579-1585
DOI: 10.26355/eurrev_202203_28224